USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
GENE SECURITY NETWORK
Address:
2686 Middlefield, Suite C
Redwood City, CA 94063-
Phone:
N/A
URL:
N/A
EIN:
841631829
DUNS:
198493095
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $994,449.00 5
SBIR Phase II $4,696,723.00 3

Award List:

Novel Statistical Methods for Improving the Prediction of HIV-1 Response to ART a

Award Year / Program / Phase:
2006 / SBIR / Phase I
Award Amount:
$178,940.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): We will develop a set of statistical techniques that improve the prediction of the response of mutated Human Immunodeficiency Virus Type 1 (HIV-1) to anti-retroviral therapy. These techniques will have applicability to a wide array of clinical decisions beyond… More

Integrating, Validating & Applying Pharmacogenetic Data

Award Year / Program / Phase:
2006 / SBIR / Phase I
Award Amount:
$218,859.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The mission of the Gene Security Network (GSN) is to create a system that enables clinicians to use aggregated genetic and phenotypic data from clinical trials and treatment records to make the safest, most effective treatment decisions for each patient. A… More

Phase I Application: Cleaning of Single Cell DNA Measurements In-Silico

Award Year / Program / Phase:
2007 / SBIR / Phase I
Award Amount:
$195,749.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): In the process of pre-implantation genetic diagnoses (PGD), a single blastomere is removed from the early stage embryo for analysis. Currently, most PGD techniques focus on detection of chromosomal abnormalities such as aneuploidies and balanced translocations.1… More

Novel Informatics for Highly Reliable Multi-Locus Allele Calling for Embryo Scree

Award Year / Program / Phase:
2008 / SBIR / Phase II
Award Amount:
$1,494,153.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): In 2006, across the globe, more than 800,000 in-vitro fertilization (IVF) cycles were run. Of 150,000 cycles run in the US, roughly 10,000 involved pre-implantation genetic diagnosis (PGD). Current PGD techniques are un regulated, expensive and highly unreliable:… More

Array informatics to understand ploidy concordance

Award Year / Program / Phase:
2009 / SBIR / Phase I
Award Amount:
$200,068.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): In each IVF cycle, a decision must be made as to which embryo(s) will be selected for transfer. This decision has a far reaching impact on the outcome of an IVF cycle, namely whether the embryo will develop into a healt hy child. It is estimated that at least 50%… More

Array informatics to understand ploidy concordance

Award Year / Program / Phase:
2009 / SBIR / Phase II
Award Amount:
$1,599,746.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): In each IVF cycle, a decision must be made as to which embryo(s) will be selected for transfer. This decision has a far reaching impact on the outcome of an IVF cycle, namely whether the embryo will develop into a healthy child. It is estimated that at least 50%… More

Non-invasive Aneuploidy Screening of Circulating Fetal Cells for Prenatal Diagnos

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$200,833.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): During the course of a pregnancy, physicians and patients desire as much information as possible regarding the health of the fetus. For both emotional and medical reasons, this information is sought as early in term as possible, and with the fewest possible… More

Non-invasive Aneuploidy Screening of Circulating Fetal Cells for Prenatal Diagnos

Award Year / Program / Phase:
2011 / SBIR / Phase II
Award Amount:
$1,602,824.00
Agency:
HHS
Principal Investigator:
Matthew Rabinowitz – 650-249-9090
Abstract:
DESCRIPTION (provided by applicant): During the course of a pregnancy, physicians and patients desire as much information as possible regarding the health of the fetus. For both emotional and medical reasons, this information is sought as early in term aspossible, and with the fewest possible risks… More